Blog

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Blog

MMRF President and CEO, Michael Andreini, reflects on urgency of the fight to find a cure for each and every myeloma patient – Multiple Myeloma Research Foundation

Photo taken from: Multiple Myeloma Research Foundation/Twitter

Nov 15, 2023, 20:54

MMRF President and CEO, Michael Andreini, reflects on urgency of the fight to find a cure for each and every myeloma patient – Multiple Myeloma Research Foundation

Multiple Myeloma Research Foundation, made the following post on Twitter:

“MMRF President and CEO, Michael Andreini, reflects on the 25 incredible years of progress and the urgency of the fight in front of us to find a cure for each and every myeloma patient. Read the 2023 edition of our Accelerator Magazine here.”

Source: Multiple Myeloma Research Foundation/Twitter

cancer Michael Andreini Multiple Myeloma Research Foundation OncoDaily Oncology

Sep 2, 2024, 11:10

Mark James C.: Part 2 of my Cancer Research UK challenge at 15000ft in memory of mum and all those who've lost loved ones to cancer

Sep 2, 2024, 11:00

Our board members are ready to commemorate Gold September - Childhood Cancer International

Sep 2, 2024, 10:54

David Fajgenbaum: It's a common misconception that approval marks the peak of a drug's journey

Sep 2, 2024, 10:42

Denise De la Cruz: Congrats to our Mary Fletcher Memorial Heart of Caring Award recipients

Sep 2, 2024, 10:12

Kelly Anderson: Gut microbiome and cancer outcomes holds great potential for future research and treatments

Sep 2, 2024, 10:00

The MDS Foundation has transformed the narrative surrounding Myelodysplastic Syndromes

Sep 2, 2024, 09:49

Bayo Curry-Winchell is a mission to make health info accessible and engaging through social media and podcasts - Women In Medicine

Sep 2, 2024, 09:38

Antonio Passaro: EMA approves amivantamab in combination with chemo for treatment of dvanced EGFR-mutated NSCLC after Osimertinib

Sep 2, 2024, 09:24

Patrick R. Benusiglio: Pathogenic germline variants were identified in patients with lung cancer

Sep 2, 2024, 09:12

George Pentheroudakis: We propose a research and regulatory framework for validation/graduation of tumour-agnostic therapies and biomarkers

Sep 2, 2024, 09:08

Sebastian Szmit: Honored to speak during Congress of the ECO

Sep 2, 2024, 09:04

Wafik El-Deiry: Some good reads in the August 23, 2024 issue of Science Magazine